ALS GuiDE Reviewed by a physician

Where to Find Stem Cell Clinics for ALS in Tijuana, Mexico

A patient-first guide to checking evidence, credentials, cell details, pricing, accessibility and follow-up before paying a deposit for investigational ALS stem cell treatment in Tijuana.

Verified
Written by Hina Munawar Patient Care Writer
Medically reviewed by Dr. Alejandro Fernando, MD, PhD Stem Cell Therapy, Longevity & Regenerative Medicine Specialist
Last updated November 18, 2026
Read time 17 minutes
In this guide

Stem cell treatment for ALS in Tijuana

A near miss before the deposit

Medical Facilities Offering Stem Cell Treatment for ALS in Tijuana, Mexico

One family’s pause at the payment screen shows why the most useful treatment question may be the one asked before money changes hands.

The family member who noticed

The invoice had a deadline. The medical plan had blanks.

Mara was ready to pay a substantial deposit for a multi-day stem cell program in Tijuana. Her husband, who has ALS, wanted to know whether the treatment might help preserve function. Their adult daughter was checking the invoice before the family booked an accessible room near the border. She noticed that the document named a “cell therapy package” but not the physician who would administer it, the cell source, the route of administration or who would answer an urgent call once her father was home.

The family stopped short of paying. They asked for those details in writing, along with the facility’s applicable Mexican authorizations, the evidence behind claims about ALS, infection-control procedures and an itemized price. They also sent the proposed plan to his U.S. neurologist. Mara, her husband and their daughter are composite characters, not accounts of identifiable patients. Their pause illustrates a decision many families face when a coordinator is responsive and a payment deadline feels more concrete than the clinical uncertainties.

Pausing did not mean rejecting the possibility of travel. It kept the family’s options open while they checked what was actually being offered. If they had paid first, they might have found themselves trying to resolve unanswered medical and financial questions while a nonrefundable payment, travel bookings and a person’s limited energy were already committed.

How the costs climb

The deposit is only the first rung

The central mistake is paying a large or nonrefundable deposit before independently checking the treating physician’s credentials, applicable facility authorizations, cell source and processing, ALS-specific evidence, emergency arrangements and follow-up responsibilities. Each missing answer can create a different cost later. The rungs below follow the order in which a family might encounter them, not a prediction that every problem will occur.

Rung 01 · Before payment

A reservation starts feeling like a medical decision

A deposit may be described as a way to hold a treatment date, secure cell processing or begin a medical review. Families can reasonably want to act quickly when ALS is changing daily routines. The problem is that a payment may become difficult to recover before the patient has enough information to judge the intervention or even knows whether the clinic considers them medically eligible. A refund policy is not a substitute for an evaluation.

Ask for the full legal name of the treating physician and their professional license information. Confirm credentials independently through the relevant Mexican professional records rather than relying only on a biography supplied by a sales representative. Ask which licensed facility will perform the evaluation and administration, what authorizations apply to the proposed activities, and whether the facility can show documentation that matches its legal name and address. Mexico’s health authority is COFEPRIS, but a general statement that a clinic is “regulated” does not tell you which part of a particular protocol is authorized.

When comparing ALS stem cell centers in Tijuana, treat directory information as a starting point for direct verification, not an endorsement or proof of authorization. Have the proposed treating clinician answer clinical questions, preferably in a consultation that includes the patient and caregiver. A coordinator can arrange that conversation, but should not replace it.

A question worth keeping beside the invoice

“If we do not pay today, which medical information will be unavailable tomorrow?”

A prompt for the family’s own discussion, not a patient testimonial.

Rung 02 · What is being administered

“Stem cells” is not a complete treatment description

Two programs using the same broad label may use different cell sources, processing methods, doses, administration routes and schedules. The cells might be described as coming from the patient or a donor. A proposed infusion is different from an injection into the spinal-fluid space, and the route changes the questions to ask about preparation, infection prevention, monitoring and potential complications. Families need the exact proposed protocol, not only a category name.

Request a written explanation of where the cells come from, who collects them, where and how they are processed, what testing is performed, how identity and traceability are documented, the intended dose and route, and how many administrations are planned. Ask who releases the product for use and what happens if testing or the patient’s evaluation does not support administration. Details may depend on the product, but a clinic should be able to explain its own process in language the patient understands.

For ALS and other motor neuron diseases, also ask which diagnosis and stage the proposed evidence actually concerns. A report about another condition, an animal study or an uncontrolled patient series cannot establish that the intervention slows ALS in an individual patient. An entry on ClinicalTrials.gov identifies a registered study, not proof that a commercial program works or that the clinic offering it is conducting that study. No stem cell product is approved by the U.S. Food and Drug Administration to treat ALS. That fact does not answer every research question, but it should shape how confidently any benefit is described.

The FDA has warned that unapproved regenerative medicine products can carry risks, including infection and inflammatory or immune reactions. Discuss the proposed route and product with the treating clinician and your U.S. ALS team. Ask what is known, what remains unknown, and which outcomes the clinic measures over time. A promise that improvement is certain is not an evidence review.

Rung 03 · Put the offer on paper

The missing lines on a tempting quote

A headline price can be useful for an initial budget, but it may not identify what happens if a consultation changes the plan. Ask for a written, itemized quotation in U.S. dollars or Mexican pesos with the conversion method stated. It should distinguish the consultation, laboratory evaluation, cell preparation, each administration, physician and facility fees, observation, medications, mobility assistance, transfers, lodging, caregiver costs, and scheduled follow-up. Check which charges are payable before medical clearance and which are refundable if the plan changes or the patient cannot travel.

Illustrative worksheet · not a clinic document

Named clinician
Full name, license details and clinical role
Cell product
Source, processing site, testing and traceability
What the price buys
Every administration and excluded service
If plans change
Refund terms, emergency costs and follow-up

Advertised multi-day investigational programs in Tijuana have broad estimated ranges of about $8,000–$30,000. These are not standardized fees and do not establish what any one patient will pay. Lodging, transfers and additional care vary. Use Tijuana ALS treatment packages to identify questions for providers, then request a patient-specific written quote directly. Do not treat a package listing as the final bill.

Set aside a separate budget for the return trip and for ordinary care at home. A fever assessment, additional testing or a changed flight is not necessarily part of a treatment package. U.S. health insurance, including Medicare, should not be assumed to cover elective care obtained in Mexico. Ask your insurer about its rules for overseas services and about coverage for medically necessary care after you return. Keep the answers and policy terms in writing.

The wider price picture

Compare scope before comparing cities

Families sometimes gather several international quotes while waiting for answers from one provider. The estimates below describe advertised-market ranges for investigational, often multi-day programs. They are not a ranking, a measure of effectiveness or a promise that ALS-specific treatment is available to a particular patient. Differences in cell products, testing, observation, rehabilitation and lodging can make two prices unlike each other even when their totals look close.

Location Broad estimated advertised range Confirm before comparing
Tijuana $8,000–$30,000 Lodging, transfers and short-term follow-up
Guadalajara $8,000–$28,000 Cell type, administrations and laboratory work
Monterrey $9,000–$30,000 Processing and hospital services
Panama City $18,000–$35,000 ALS eligibility and program inclusions
Bangkok $15,000–$40,000 Hospital care, rehabilitation and lodging
United States No comparable approved-treatment price Research eligibility and separate routine or travel costs

In the United States, there is no FDA-approved stem cell product for ALS. Eligible research studies generally provide the investigational product without charging participants for that product, while routine care, tests, travel, lodging or noncovered services may still cost money. Medicare’s clinical-trial coverage rules and a study’s own payment arrangements are separate questions. Someone with ALS may qualify for Medicare under ALS-specific rules, but should confirm their own coverage rather than assuming an international treatment or every research-related expense is paid.

If you compare destinations, give particular weight to safety, regulatory transparency and physician qualifications. Next examine the actual protocol and evidence, then the quality of follow-up. Only after those checks should price, U.S. travel access, caregiver support and communication settle a close choice. A less expensive quote with an unclear cell source or no reachable clinical contact is not an equivalent offer.

Rung 04 · Getting there and back

A short border crossing is still a medical trip

Tijuana’s proximity to San Diego can make travel more manageable for some U.S. families, including those who prefer to fly to San Diego and continue by ground transport. It does not remove the need to plan for border wait times, wheelchair-accessible vehicles, fatigue, meals, medication timing and an unexpected delay. A patient who uses a power wheelchair should confirm vehicle dimensions and loading arrangements rather than accepting a general promise of “accessible transfers.”

Many proposed programs call for a stay of roughly 5–10 days, depending on evaluation, the number and route of administrations, mobility needs, observation and clearance to return. Build room into travel bookings if the physician advises more observation or decides not to proceed. Ask who assists with transfers between bed, vehicle and examination table, whether a caregiver may remain overnight, and what equipment the facility can accommodate. If swallowing, breathing or communication is affected, describe those needs before booking rather than assuming the team can infer them from the ALS diagnosis.

Bring a current medication list, equipment specifications, recent clinical notes and your U.S. clinician’s contact details. Discuss travel fitness with your ALS team, especially if you use noninvasive ventilation, cough-assist equipment or supplemental oxygen. Airlines have their own equipment and battery requirements. Your clinician can advise whether a flight or a prolonged ground journey is appropriate for you.

Comparing ALS stem cell doctors in Tijuana may help you identify whom to interview. Ask the actual treating physician to explain who performs each procedure, who covers nights and weekends, and where a patient would receive urgent evaluation. Emergency planning matters even when treatment and travel go as expected.

Rung 05 · The handoff home

The treatment record must travel before the patient needs it

Consider what would happen if a patient returned to the United States and developed a fever, increasing weakness, new swallowing difficulty or a change in breathing. Their local team would need to know what was administered, when and by which route. If the home neurologist had not received the treatment record, laboratory results, cell-product details or a direct number for the Tijuana medical team, assessment could begin with avoidable gaps. The clinician may need to repeat questions or tests while the family tries to reach someone across the border.

This is not a reason to expect a complication. It is a reason to arrange a handoff while everyone is available. Before discharge, request a legible record in a language your U.S. clinicians can use. It should identify the physician and facility, cell-product source and available traceability information, administration dates and routes, doses, relevant laboratory results, medicines given, any events during care and written instructions. Ask the clinic to send the record directly to your home neurologist with your permission and give you your own copy. Agree on who will respond to questions after hours and how long that support continues.

Make a follow-up appointment with your regular ALS team before leaving home, then tell them if the treatment plan changes. The clinic abroad should specify what it will monitor and when. Your U.S. clinicians remain essential for established ALS care, respiratory and swallowing assessment, symptom management and local evaluation. Do not stop prescribed medicines or postpone usual visits because an investigational program is scheduled.

A second question for the family’s notes

“If we call our home clinic from the airport, will they already have the information they need?”

A planning prompt, not a claim about an actual patient.

If the deposit is already paid

You can still slow the decision down

Paying early is understandable, particularly when symptoms are progressing and an available date seems valuable. It does not obligate you to proceed without answers. Save the advertisement, invoice, messages, payment receipt, consent forms and refund terms. Ask the provider in writing to pause further charges and clarify whether your deposit is refundable, transferable or tied to a particular service. Request the named physician, protocol, authorizations, itemized costs and follow-up plan before making another payment.

If the replies change what you believed you were buying, ask the provider to explain the difference and its cancellation process in writing. Your card issuer may be able to explain dispute procedures, but a refund is not assured. Do not let a dispute deadline replace a medical discussion. Share the proposed treatment and any records you have with your U.S. neurologist so they can help assess suitability and plan ongoing care.

If you have already received treatment and feel unwell, seek local medical assessment promptly. Fever, increasing weakness or new swallowing difficulty deserves timely clinical advice. For serious or rapidly changing breathing problems, call 911 in the United States. Tell the assessing team about the intervention even if your complete records have not arrived, then ask the Tijuana team to send them directly.

Make the pause useful

What a complete answer sounds like

A useful provider response does more than say a treatment is safe, personalized or promising. It identifies the clinician responsible for eligibility and administration, supplies a protocol specific enough to review, explains the limits of evidence for the patient’s diagnosis, and describes who handles a change in health. It also distinguishes routine short-term contact from meaningful long-term follow-up. Ask when the clinic will check in, what it measures, how adverse events are reported and what information it will share with your home team.

Independent verification can be spread across several conversations. A family member can check credentials and the legal facility name. The patient and U.S. neurologist can review the proposed clinical plan. The caregiver can test the travel and accessibility arrangements. Someone can compare the written quote against the refund policy line by line. This divides the work without asking one exhausted person to become an expert in medical regulation, cell processing, insurance and border travel all at once.

For additional background, Tijuana ALS stem cell articles can help you build a reading list. Check any clinical claim against the underlying evidence and discuss it with your own clinician. If a provider cannot answer a material question before payment, it is reasonable to wait, seek a second opinion or examine research-study options instead.

Keep this beside the travel documents

Five checks before departure

The family in the opening did not need to predict every outcome. They needed enough clear information to make a choice they could explain to themselves and to their home care team. This short list is the point of the longer cost ladder. The opening family is composite, and its near miss is an illustration rather than a reported case.

  1. 01 · Verify the people and place. Independently check the treating physician’s credentials, the facility’s identity and the applicable Mexican authorizations.
  2. 02 · Review the exact protocol. Obtain cell-source, processing, testing, dose and route details, plus a candid explanation of the evidence and uncertainties for ALS.
  3. 03 · Reconcile every dollar. Get an itemized written quote, deposit and refund rules, and the costs of travel, caregiver support and services not included.
  4. 04 · Test the travel and emergency plan. Confirm mobility assistance, equipment arrangements, observation, urgent-care access and medical clearance for the return trip.
  5. 05 · Arrange the handoff home. Book follow-up with your U.S. ALS team and confirm that records, cell-product details and direct clinical contact information will reach them.

Practical questions

Questions U.S. patients ask about ALS stem cell care in Tijuana

Is stem cell therapy in Tijuana proven to slow ALS?

No stem cell treatment has been established as a proven way to slow ALS, and no stem cell product is FDA-approved for ALS. Research continues, but a clinic should explain which published evidence supports its specific product and protocol. Ask your ALS neurologist to help distinguish an investigational intervention from an established treatment.

How much should I budget beyond the advertised program price?

Budget for expenses the written quote excludes, which may include accessible lodging, a caregiver, ground transport, changed travel dates, additional tests and care at home. Ask whether observation, medications and follow-up are included. Keep an emergency reserve, since an advertised package price does not set the cost of an unexpected medical assessment.

Can I fly home immediately after an administration?

That depends on the administration route, your condition and the treating physician’s observation requirements. Do not assume a same-day return is appropriate because the border is nearby. Discuss travel fitness with both the Tijuana clinician and your home ALS team, particularly if breathing support, swallowing changes or significant fatigue affect the journey.

Will Medicare or my U.S. insurance pay for the treatment?

Do not assume either will pay for elective investigational treatment in Mexico. Ask your plan directly about overseas care and about medically necessary assessment after you return. If you are considering a U.S. clinical study, ask its team what the study pays for and which routine costs may fall under your coverage.

What if my symptoms change after I get home?

Contact your local clinical team promptly for a fever, increasing weakness or new swallowing difficulty, and call 911 for serious or rapidly changing breathing problems. Tell the team what treatment you received. Keep your discharge record available and ask the Tijuana physician to send any missing product and laboratory details directly to your clinicians.

Does a registered clinical study mean a clinic’s package is approved?

No. Study registration does not establish that a treatment works, that it has regulatory approval or that a separately advertised package is part of that study. Ask for the study identifier, eligibility criteria, named study site and investigator. Check these details independently, then discuss the study and any proposed commercial treatment with your neurologist.

 

Review record Current
How this article was checked
Reviewed by
Dr. Alejandro Fernando Stem Cell Therapy, Longevity & Regenerative Medicine Specialist
Review date
November 18, 2026
Evidence basis
Peer-reviewed literature & clinical guidance
ARTICLE NAVIGATION
In this guide

Request treatment information

Tell us what you are trying to find out. A coordinator replies with information — not a diagnosis.

Submitted over a secure connection
No cost and no obligation to proceed
Typical reply within one business day
Accountability

Who stands behind this article

Health content should never be anonymous. Here are the people who wrote and checked it, with credentials you can verify independently.

Article written by

Hina Munawar

This author specializes in global healthcare trends and medical education. By focusing on evidence-based practices and a patient-first approach, they provide accessible resources to help readers navigate their international treatment options with clarity.

Editorial focus Stem cell therapy, regenerative medicine and patient education
Content approach Research-informed, understandable and non-promotional
Medically reviewed by
Dr. Alejandro Fernando

Dr. Alejandro Fernando

Stem Cell Therapy, Longevity & Regenerative Medicine Specialist

Dr. Alejandro Fernando is a Mexico City-based physician and medical content reviewer focused on stem cell therapy, regenerative medicine, cellular therapy and longevity medicine. His reviewer profile lists medical and postgraduate training related to regenerative medicine, cellular therapy and stem cell biology.

Doctor of Medicine PhD in Regenerative Medicine & Cellular Therapy Stem Cell and Regenerative Medicine Mexico City, Mexico English and Spanish
View medical reviewer profile
Ministry-licensed facilitiesLicence numbers published
Board-certified physiciansRegistrations verifiable
Independent lab verificationThird-party testing
Editorially reviewed contentSources cited on every page
Keep reading

Related patient guides

More guides written and reviewed to the same standard.

Discover the benefits of regenerative medicine for ALS. Explore cutting-edge treatments that aim to slow progression and enhance quality of life. Contact us now
A patient-first truth ledger on stem cell therapy for ALS in Mexico, covering evidence, clinic checks, costs, travel safety, and follow-up care for Americans.
ALS is a type of motor neuron ailment that attacks the nerve cells that controls the voluntary muscles. Learn how stem cell treatment for ALS can help.
GSC Logo X
send